Diabetes News and Research

Latest Diabetes News and Research

Study links expanding GLP-1 use with rising overall costs

As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022.

16 Jul 2026

Early PFAS exposure linked to childhood intestinal inflammation

Researchers at the Icahn School of Medicine at Mount Sinai have found that exposure to per- and polyfluoroalkyl substances (PFAS), commonly known as "forever chemicals," during pregnancy and early life is associated with increased intestinal inflammation during childhood.

16 Jul 2026

AI-based nursing interventions can improve care of people living with chronic illnesses

Artificial intelligence (AI) is helping nurses better predict health problems before they become emergencies, according to a new review of existing research published in JMIR Nursing.

16 Jul 2026

Study finds some sweeteners can slow the growth of gut bacteria

Cambridge researchers have shown how commonly-used sweeteners slow the growth of certain gut bacteria.

16 Jul 2026

WHO updates guidelines to reduce risk of dementia worldwide

The World Health Organization (WHO) today released updated guidelines on reducing the risk of cognitive decline and dementia, providing countries with evidence-based recommendations to help prevent or delay the onset of dementia across the life course.

16 Jul 2026

Blood ketone threshold may help predict weight loss success

Achieving and sustaining a blood ketone level of 0.5 mmol/L is crucial for weight loss in ketogenic diets, offering a new approach to dietary monitoring.

16 Jul 2026

New body mass index could overcome limitations of BMI

The Consistent Body Mass Index (CBMI) offers a promising alternative to traditional BMI, aligning with waist-to-height ratio for better body size assessment.

16 Jul 2026

Fractyl Health reports positive randomized data from REMAIN-1 Midpoint Cohort demonstrating durable weight maintenance one year after GLP-1 discontinuation

Fractyl Health, Inc. (Fractyl), a clinical-stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced positive one-year results from its REMAIN-1 Midpoint Cohort (“Midpoint Cohort”).

16 Jul 2026

Epidurals during labor show no significant risks to newborns

Having an epidural during labor is not associated with clinically significant increased risks of harm to newborn babies, including brain injury, severe breathing problems, sepsis and death, or cerebral palsy later in childhood.

15 Jul 2026

Experts recommend renaming PCOS to better reflect whole-body impacts

A condition affecting approximately 170 million adolescents and women worldwide has a new name – one that better reflects its complexity and far-reaching health impacts.

15 Jul 2026

Lactoferrin yogurt helps preserve iron stores in women with gestational diabetes

In a double-blind pilot trial, lactoferrin-enriched yogurt added to routine iron supplementation helped prevent ferritin decline in pregnant women with gestational diabetes and reduced iron stores. The intervention was well tolerated and produced modest changes in selected gut bacteria, but did not significantly improve anemia or metabolic outcomes.

15 Jul 2026

New project documents vanishing heritage diets for future health benefits

The world's 'heritage' diets could hold vital clues to better health. Writing in Nature Medicine, researchers from 12 countries have launched the World Diet Initiative, a global effort to document and study these diets before this knowledge is lost.

15 Jul 2026

Why dementia prevention should be tailored by country

An international study reveals common clusters of dementia risk factors, highlighting the need for tailored prevention strategies across diverse populations.

15 Jul 2026

GLP-1 receptor activation linked to lower depression and bipolar disorder odds

Genetic analyses linked BMI-related GLP-1 receptor activation to better mental well-being and lower odds of major depressive disorder and bipolar disorder. The findings do not prove that GLP-1 receptor agonist drugs treat psychiatric conditions, and randomized clinical trials are still needed.

15 Jul 2026

Breast and prostate cancer survival worsens with metabolic syndrome

A SEER-Medicare analysis of more than 200,000 adults aged 66 and older found that metabolic syndrome was associated with about twice the adjusted hazard of death from any cause after breast or prostate cancer. The condition was also linked to higher cancer-specific, cardiovascular-specific, and liver-failure-specific mortality, although the observational design prevents causal conclusions.

14 Jul 2026

Experts urge Mexico to integrate liver disease into chronic care

Liver disease may affect close to half of adults in Mexico, yet the country tracks it far less closely than the diabetes and obesity to which it is linked, according to a new paper by Jeffrey Lazarus, professor at the CUNY Graduate School of Public Health and Health Policy Professor (CUNY SPH), and colleagues, and released to coincide with the International Congress on Obesity taking place in Mexico City this week.

14 Jul 2026

Fear of new foods may affect more than dietary variety

Higher food neophobia was associated with poorer self-reported physical and mental health among 4,537 adults in Australia, the United Kingdom, and the United States. The relationship remained after accounting for age, gender, education, and country, although the cross-sectional study could not establish causation.

14 Jul 2026